Equity Analysis /
United States of America

US : Passage Bio, Inc. - PASG | 3Q Update: Initial Data Timelines Reaffirmed for 4Q21 and 1H22 Despite COVID Related Delays

    Danielle Brill
    CGS-CIMB
    4 November 2021
    Published by